NO973441L - Substituerte fenylforbindelser som endotelinantagonister - Google Patents
Substituerte fenylforbindelser som endotelinantagonisterInfo
- Publication number
- NO973441L NO973441L NO973441A NO973441A NO973441L NO 973441 L NO973441 L NO 973441L NO 973441 A NO973441 A NO 973441A NO 973441 A NO973441 A NO 973441A NO 973441 L NO973441 L NO 973441L
- Authority
- NO
- Norway
- Prior art keywords
- aryl
- heteroaryl
- substituted phenyl
- optionally substituted
- endothelin antagonists
- Prior art date
Links
- 102000002045 Endothelin Human genes 0.000 title 1
- 108050009340 Endothelin Proteins 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 title 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 title 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 4
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000004414 alkyl thio group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000002308 endothelin receptor antagonist Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
- 229910052717 sulfur Chemical group 0.000 abstract 1
- 239000011593 sulfur Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/54—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Forbindelser med formel (I) er beskrevet hvori Rer CN, CHCN, CH-CHCN, CHO eller CH=CC0; R2 er aryl lavere alkoksy, heteroaryl lavere alkoksy, aryl lavere alkyltio eller heteroaryl lavere alkyltio, hvori hver av aryl- og heteroarylgruppene er alternativt substituert, Rer halogen, R" er alternativt substituert aryl eller alternativt substituert heteroaryl, Rer karboksy eller en syre-isoster; X er oksygen eller svovel, og n er 0 eller; og deres N-oksider og prodroger, og farmasøytisk akseptable salter derav. Forbindelsene har endo-telinantagonist-aktivitet og er nyttige som lege-midler .
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9501635.8A GB9501635D0 (en) | 1995-01-27 | 1995-01-27 | Chemical compounds |
| GBGB9504061.4A GB9504061D0 (en) | 1995-03-01 | 1995-03-01 | Chemical compounds |
| GBGB9509604.6A GB9509604D0 (en) | 1995-05-11 | 1995-05-11 | Chemical compounds |
| PCT/GB1996/000120 WO1996022978A1 (en) | 1995-01-27 | 1996-01-22 | Substituted phenyl compounds as endothelin antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO973441D0 NO973441D0 (no) | 1997-07-25 |
| NO973441L true NO973441L (no) | 1997-09-15 |
Family
ID=27267564
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO973441A NO973441L (no) | 1995-01-27 | 1997-07-25 | Substituerte fenylforbindelser som endotelinantagonister |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0805802B1 (no) |
| JP (1) | JP3901729B2 (no) |
| KR (1) | KR19980701690A (no) |
| AT (1) | ATE195516T1 (no) |
| AU (1) | AU706940B2 (no) |
| BR (1) | BR9606961A (no) |
| CA (1) | CA2211646C (no) |
| CZ (1) | CZ223697A3 (no) |
| DE (1) | DE69609812D1 (no) |
| EA (1) | EA000061B1 (no) |
| FI (1) | FI973111A (no) |
| HU (1) | HUP9801938A3 (no) |
| IL (1) | IL116907A0 (no) |
| MX (1) | MX9705649A (no) |
| NO (1) | NO973441L (no) |
| NZ (1) | NZ298853A (no) |
| PL (1) | PL184060B1 (no) |
| WO (1) | WO1996022978A1 (no) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6030975A (en) * | 1997-03-14 | 2000-02-29 | Basf Aktiengesellschaft | Carboxylic acid derivatives, their preparation and use in treating cancer |
| AU750755B2 (en) * | 1997-09-26 | 2002-07-25 | Abbvie Deutschland Gmbh & Co Kg | Endothelin antagonist and a renin-angiotensin system inhibitor as a combined preparation |
| DE19743142A1 (de) * | 1997-09-30 | 1999-04-01 | Knoll Ag | Pharmazeutische Kombinationspräparate |
| DE19743143A1 (de) | 1997-09-30 | 1999-04-01 | Knoll Ag | Pharmazeutische Kombinationspräparate |
| WO1999048530A1 (en) * | 1998-03-23 | 1999-09-30 | Merck & Co., Inc. | Combination therapy for the treatment of benign prostatic hyperplasia |
| US6410554B1 (en) | 1998-03-23 | 2002-06-25 | Merck & Co., Inc. | Combination therapy for the treatment of benign prostatic hyperplasia |
| US8168616B1 (en) | 2000-11-17 | 2012-05-01 | Novartis Ag | Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension |
| NZ536918A (en) * | 2002-05-07 | 2006-09-29 | Altana Pharma Ag | Combination of pantoprazole and a respiratory agent for the treatment of respiratory diseases |
| US20050222193A1 (en) * | 2002-05-07 | 2005-10-06 | Guido Hanauer | Novel combination for the treatment of airway disorders |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0617001B1 (en) * | 1993-03-19 | 2000-01-26 | Merck & Co. Inc. | Phenoxyphenylacetic acid derivatives |
-
1996
- 1996-01-22 CA CA002211646A patent/CA2211646C/en not_active Expired - Lifetime
- 1996-01-22 JP JP52270896A patent/JP3901729B2/ja not_active Expired - Lifetime
- 1996-01-22 DE DE69609812T patent/DE69609812D1/de not_active Expired - Lifetime
- 1996-01-22 AT AT96900634T patent/ATE195516T1/de not_active IP Right Cessation
- 1996-01-22 BR BR9606961A patent/BR9606961A/pt unknown
- 1996-01-22 EA EA199700147A patent/EA000061B1/ru not_active IP Right Cessation
- 1996-01-22 AU AU44541/96A patent/AU706940B2/en not_active Expired
- 1996-01-22 EP EP96900634A patent/EP0805802B1/en not_active Expired - Lifetime
- 1996-01-22 WO PCT/GB1996/000120 patent/WO1996022978A1/en not_active Application Discontinuation
- 1996-01-22 NZ NZ298853A patent/NZ298853A/en unknown
- 1996-01-22 HU HU9801938A patent/HUP9801938A3/hu unknown
- 1996-01-22 CZ CZ972236A patent/CZ223697A3/cs unknown
- 1996-01-22 KR KR1019970705086A patent/KR19980701690A/ko not_active Application Discontinuation
- 1996-01-22 PL PL96321545A patent/PL184060B1/pl unknown
- 1996-01-25 IL IL11690796A patent/IL116907A0/xx unknown
-
1997
- 1997-07-25 FI FI973111A patent/FI973111A/fi unknown
- 1997-07-25 NO NO973441A patent/NO973441L/no unknown
- 1997-07-25 MX MX9705649A patent/MX9705649A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL116907A0 (en) | 1996-05-14 |
| PL184060B1 (pl) | 2002-08-30 |
| FI973111A (fi) | 1997-09-25 |
| EA199700147A1 (ru) | 1997-12-30 |
| PL321545A1 (en) | 1997-12-08 |
| ATE195516T1 (de) | 2000-09-15 |
| NO973441D0 (no) | 1997-07-25 |
| JPH10513158A (ja) | 1998-12-15 |
| CA2211646C (en) | 2008-09-09 |
| EP0805802B1 (en) | 2000-08-16 |
| CZ223697A3 (en) | 1997-12-17 |
| DE69609812D1 (de) | 2000-09-21 |
| HUP9801938A2 (hu) | 1999-05-28 |
| EP0805802A1 (en) | 1997-11-12 |
| HUP9801938A3 (en) | 1999-10-28 |
| AU4454196A (en) | 1996-08-14 |
| JP3901729B2 (ja) | 2007-04-04 |
| NZ298853A (en) | 1998-07-28 |
| EA000061B1 (ru) | 1998-04-30 |
| KR19980701690A (ko) | 1998-06-25 |
| MX9705649A (es) | 1998-07-31 |
| FI973111A0 (fi) | 1997-07-25 |
| AU706940B2 (en) | 1999-07-01 |
| BR9606961A (pt) | 1997-11-04 |
| CA2211646A1 (en) | 1996-08-01 |
| WO1996022978A1 (en) | 1996-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69819891D1 (de) | Spiro chinuclidin-derivate, ihre herstellung und verwendung | |
| NZ308619A (en) | N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists | |
| PT863875E (pt) | Novos compostos 4-(oxialcoxifenil)-3-oxi-piperidina para o tratamento de insuficiencia cardiaca e renal | |
| DK249989D0 (da) | Aryl- og heteroarylpiperazinylcarboxamider eller farmaceutisk salte deraf, deres fremstilling og anvendelse | |
| EP0244115A3 (en) | Phenyl-piperazine anti-arrhythmia agents | |
| NO20052733L (no) | C-6 modifiserte indazolylpyrrolotriaziner | |
| NO20023218L (no) | 2-amino-nikotinamidderivater og deres anvendelse som VEGF- reseptor tyrosinkinaseinhibitorer | |
| HUP0102793A2 (hu) | Agydaganat kezelésére szolgáló kinazolinok és ezeket tartalmazó gyógyszerkészítmények | |
| NO954453L (no) | Nye pyridin-, pyrimidin- og benzenderivater som adreno-ceptorantagonister | |
| NO973441L (no) | Substituerte fenylforbindelser som endotelinantagonister | |
| DE60305514D1 (de) | Neue verwendung von benzothiazolderivaten | |
| MX9602493A (es) | Aril y heteroaril pirimidinas herbicidas. | |
| JP2005538111A5 (no) | ||
| NZ528997A (en) | Sulfonamides | |
| WO2002042280A3 (en) | Pyrimidine derivatives | |
| DE60009868T2 (de) | Anti-tumor dihydrochinazolindervate | |
| WO1998031704A3 (en) | Tachykinin antagonists | |
| NO20020885L (no) | <alfa>v<beta>3-integrininhibitorer | |
| KR880009005A (ko) | 치환된 디옥솔란 및 디옥산 유도체 | |
| ATE388945T1 (de) | Benzoxazolderivate und deren verwendung als adenosinrezeptorliganden | |
| DE69120221D1 (de) | Pyrimidin-verbindung und ihr pharmazeutisch annehmbares salz | |
| NO971424L (no) | Nye heterocyklisk substituerte imidazolo-kinoksalinoner, deres fremstilling og anvendelse | |
| DK1245564T3 (da) | Benzamidinderivater | |
| NO20010626L (no) | N-substituerte azabicykloheptanderivater, deres fremstilling og anvendelse | |
| NO20020886L (no) | Nye integrin- <alfa>v<beta>3-inhibitorer |